SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-201193
Filing Date
2014-05-15
Accepted
2014-05-15 16:12:39
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d696223d10q.htm 10-Q 199247
2 EX-31.1 d696223dex311.htm EX-31.1 7447
3 EX-31.2 d696223dex312.htm EX-31.2 7475
4 EX-32.1 d696223dex321.htm EX-32.1 7057
  Complete submission text file 0001193125-14-201193.txt   2808300

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT qhoi-20140331.xml EX-101.INS 225690
6 XBRL TAXONOMY EXTENSION SCHEMA qhoi-20140331.xsd EX-101.SCH 48023
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qhoi-20140331_cal.xml EX-101.CAL 33884
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qhoi-20140331_def.xml EX-101.DEF 107330
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE qhoi-20140331_lab.xml EX-101.LAB 544764
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qhoi-20140331_pre.xml EX-101.PRE 225228
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52062 | Film No.: 14847349
SIC: 2834 Pharmaceutical Preparations